Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats

European Journal of Pharmacology

Volumn 565, Issue 1-3, 2007, Pages 89-97

  Yoshikawa, Masanobu ^a   Ito, Kenji ^a   Maeda, Miho ^a   Akahori, Kazuhito ^a   Takahashi, Shigeru ^a   Jin, Xing Lu ^a   Matsuda, Mitsumasa ^a   Suzuki, Toshiyasu ^a   Oka, Tetsuo ^a   Kobayashi, Hiroyuki ^a   Hashimoto, Atsushi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antinociception; D serine; Morphine; NMDA receptor; Tail flick test

Indexed keywords

DEXTRO SERINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TAIL FLICK TEST;

ANALGESICS; ANIMALS; DRUG SYNERGISM; MALE; MORPHINE; NALOXONE; PAIN MEASUREMENT; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU; SERINE; SPINAL CORD; STEREOISOMERISM;

EID: 34249073110     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.042     Document Type: Article

References (43)

1. Advokat C., and Rutherford D. Selective antinociceptive effect of excitatory amino acid antagonists in intact and acute spinal rats. Pharmacol. Biochem. Behav. 51 (1995) 855-860
2. Bach F.W., and Yaksh T.L. Release of beta-endorphin immunoreactivity from brain by activation of a hypothalamic N-methyl-D-aspartate receptor. Neuroscience 65 (1995) 775-783
3. Bernardi M., Bertolini A., Szczawinska K., and Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur. J. Pharmacol. 298 (1996) 51-55
4. Danysz W., and Parsons A.C. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50 (1998) 597-664
5. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., and Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56 (1994) 69-75
6. Fields H. State-dependent opioid control of pain. Nat. Rev., Neurosci. 5 (2004) 565-575
7. Fukui K., and Miyake Y. Molecular cloning and chromosomal localization of a human gene encoding D-amino-acid oxidase. J. Biol. Chem. 267 (1992) 18631-18638
8. Hashimoto A. Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res. 955 (2002) 214-220
9. Hashimoto A., and Chiba Y. Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat. Eur. J. Pharmacol. 495 (2004) 153-158
10. Hashimoto A., and Oka T. Free D-aspartate and D-serine in the mammalian brain and periphery. Prog. Neurobiol. 52 (1997) 325-353
11. Hashimoto A., Nishikawa T., Oka T., and Takahashi K. Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J. Neurochem. 60 (1993) 783-786
12. Heinricher M.M., and Roychowdhury S.M. Reflex-related activation of putative pain facilitating neurons in rostral ventromedial medulla requires excitatory amino acid transmission. Neuroscience 78 (1997) 1159-1165
13. Heinricher M.M., McGaraughty S., and Tortorici V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J. Neurophysiol. 85 (2001) 280-286
14. Horiike K., Tojo H., Arai R., Nozaki M., and Maeda T. D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994) 297-303
15. Hunter J., Atwal P., Woodruff G., and Singh L. Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine. Br. J. Pharmacol. 112 (1994) 1002-1003
16. Jacquet Y.F. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Eur. J. Pharmacol. 154 (1988) 271-276
17. Kitamura K., Akahori K., Yano H., Iwao K., and Oka T. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1-8) in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 361 (2000) 273-278
18. Konno R. Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus. Neurosci. Lett. 349 (2003) 111-114
19. Kozela E., Danysz W., and Popik P. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur. J. Pharmacol. 423 (2001) 17-26
20. Lutfy K., Hurlbut D.E., and Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616 (1993) 83-88
21. Lutfy K., Doan P., and Weber E. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol. Res. 40 (1999) 435-442
22. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Rev. 30 (1999) 289-304
23. Marek P., Ben-Eliyahu S., Gold M., and Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547 (1991) 77-81
24. Millan M.J., Audinot V., Honore P., Bervoets K., Veiga S., and Brocco M. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats. Eur. J. Pharmacol. 388 (2000) 37-47
25. Nemmani K.V., Grisel J.E., Stowe J.R., Smith-Carliss R., and Mogil J.S. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109 (2004) 274-283
26. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
27. Plesan A., Hoffmann O., Xu X.J., and Wiesenfeld-Hallin Z. Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats. Neurosci. Lett. 263 (1999) 53-56
28. Redwine K.E., and Trujillo K.A. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Pharmacol. Biochem. Behav. 76 (2003) 361-372
29. Ruzicka B.B., and Jhamandas K. Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids. J. Pharmacol. Exp. Ther. 257 (1991) 1025-1033
30. Schell M.J., Molliver M.E., and Snyder S.H. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
31. Spinella M., Cooper M.L., and Bodnar R.J. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain 64 (1996) 545-552
32. Suh H.W., Song D.K., Kim Y.H., Yoo J.S., and Tseng L.F. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice. Eur. J. Pharmacol. 263 (1994) 217-221
33. Tallarida R.J. Drug synergism: its detection and applications. J. Pharmacol. Exp. Ther. 298 (2001) 865-872
34. Taniguchi T., Fan X.T., Kitamura K., and Oka T. Effects of peptidase inhibitors on the enkephalin-induced anti-nociception in rats. Jpn. J. Pharmacol. 78 (1998) 487-492
35. Tham S.M., Angus J.A., Tudor E.M., and Wright C.E. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice. Br. J. Pharmacol. 144 (2005) 875-884
36. Tiseo P.J., and Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264 (1993) 1090-1096
37. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
38. van Praag H., and Frenk H. The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes. Brain Res. 524 (1990) 101-105
39. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414
40. Yang Z., Copolov D.L., and Lim A.T. Glutamate enhances the adenylyl cyclase-cAMP system-induced beta-endorphin secretion and POMC mRNA expression in rat hypothalamic neurons in culture: NMDA receptor-mediated modulation. Brain Res. 692 (1995) 129-136
41. Yoshikawa M., Kobayashi T., Oka T., Kawaguchi M., and Hashimoto A. Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR. Mol. Brain Res. 128 (2004) 90-94
42. Yoshikawa M., Oka T., Kawaguchi M., and Hashimoto A. MK-801 upregulates the expression of D-amino acid oxidase mRNA in rat brain. Mol. Brain Res. 131 (2004) 141-144
43. Yoshikawa M., Andoh H., Ito K., Suzuki T., Kawaguchi M., Kobayashi H., Oka T., and Hashimoto A. Acute treatment with morphine augments the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain. Eur. J. Pharmacol. 525 (2005) 94-97